As of May 01
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 3.00, with a high estimate of 15.00 and a low estimate of 2.50. The median estimate represents a +50.75% increase from the last price of 1.99.
The current consensus among 7 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.